JENNIFER CALUORI: Open Payments
NPI 1639415789 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,694 in 93 payments from 20 companies in 2025. Trend: 2023 $794 · 2024 $1,592 · 2025 $1,694
Food & beverage: $1,694
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $348 |
| Esperion Therapeutics, Inc. | 10 | $191 |
| Amgen Inc. | 14 | $190 |
| GlaxoSmithKline, LLC. | 12 | $141 |
| PFIZER INC. | 5 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Novo Nordisk Inc | 4 | $85 |
| Eisai Inc. | 3 | $77 |
| Lilly USA, LLC | 3 | $64 |
Products named: QULIPTA, NEXLETOL, TRELEGY ELLIPTA, OTEZLA, NURTEC ODT, XIFAXAN, GEMTESA, Leqembi.
Industry payments across FL — which companies pay providers there.
